Neudesin may serve as a potential diagnostic tool for GDM. Future investigations into neudesin as a novel GDM biomarker and potential therapeutic target are urgently warranted.
Moussa et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: